ArticleThe Lancet. Oncology2017
Another treatment option for relapsed or refractory chronic lymphocytic leukaemia.
Francesca R MauroPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2017
Francesca R MauroPubMed ↗Publisher ↗
No numbers read from the abstract.